BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 32739464)

  • 21. Association between ABO blood group and COVID-19 infection: an updated systematic review and meta-analysis.
    Gheshlagh RG; Ansari M; Dalvand P; Shabani F; Albatineh AN
    Immunohematology; 2022 Apr; 38(1):5-12. PubMed ID: 35852057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood system ABO antigens as risk factor for severity of SARS-CoV-2 infection.
    Torres-Alarcón CG; García-Ruíz A; Cañete-Ibáñez CR; Morales-Pogoda II; Muñoz-Arce CM; Cid-Domínguez BE; Montalvo-Bárcenas M; Torre GM; Sandoval-López C; Gaytán-Guzmán E; Correo-Zamora JD
    Gac Med Mex; 2021; 157(2):174-180. PubMed ID: 34270530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O.
    Barnkob MB; Pottegård A; Støvring H; Haunstrup TM; Homburg K; Larsen R; Hansen MB; Titlestad K; Aagaard B; Møller BK; Barington T
    Blood Adv; 2020 Oct; 4(20):4990-4993. PubMed ID: 33057631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.
    Henry BM; de Oliveira MHS; Benoit S; Plebani M; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1021-1028. PubMed ID: 32286245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tocilizumab for severe COVID-19: a systematic review and meta-analysis.
    Lan SH; Lai CC; Huang HT; Chang SP; Lu LC; Hsueh PR
    Int J Antimicrob Agents; 2020 Sep; 56(3):106103. PubMed ID: 32712333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of ABO blood group to COVID-19 infections: clinico-hematological, radiological, and complications analysis.
    Kabrah SM; Abuzerr SS; Baghdadi MA; Kabrah AM; Flemban AF; Bahwerth FS; Assaggaf HM; Alanazi EA; Alhifany AA; Al-Shareef SA; Alsabban WH; Khan AA; Alzhrani H; Jambi LK; Alsafi RT; Aslam A; Kabrah HM; Babalghith AO; Halawani AJ
    Medicine (Baltimore); 2021 Dec; 100(52):e28334. PubMed ID: 34967364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of ABO and Rh Blood Group in Susceptibility, Severity, and Mortality of Coronavirus Disease 2019: A Hospital-Based Study From Delhi, India.
    Rana R; Ranjan V; Kumar N
    Front Cell Infect Microbiol; 2021; 11():767771. PubMed ID: 34796130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
    Gemmati D; Bramanti B; Serino ML; Secchiero P; Zauli G; Tisato V
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia.
    De Biasi S; Lo Tartaro D; Meschiari M; Gibellini L; Bellinazzi C; Borella R; Fidanza L; Mattioli M; Paolini A; Gozzi L; Jaacoub D; Faltoni M; Volpi S; Milić J; Sita M; Sarti M; Pucillo C; Girardis M; Guaraldi G; Mussini C; Cossarizza A
    Eur J Immunol; 2020 Sep; 50(9):1283-1294. PubMed ID: 32910469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection and thrombosis associated with COVID-19: Possible role of the ABO blood group.
    Zalba Marcos S; Antelo ML; Galbete A; Etayo M; Ongay E; García-Erce JA
    Med Clin (Barc); 2020 Oct; 155(8):340-343. PubMed ID: 32814635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis.
    Khan MMA; Khan MN; Mustagir MG; Rana J; Islam MS; Kabir MI
    J Glob Health; 2020 Dec; 10(2):020503. PubMed ID: 33110586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review and meta-analysis of the susceptibility of ABO blood group to COVID-19 infection.
    Kabrah SM; Kabrah AM; Flemban AF; Abuzerr S
    Transfus Apher Sci; 2021 Aug; 60(4):103169. PubMed ID: 34045120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABO blood group and COVID-19: an updated systematic literature review and meta-analysis.
    Franchini M; Cruciani M; Mengoli C; Marano G; Candura F; Lopez N; Pati I; Pupella S; De Angelis V
    Blood Transfus; 2021 Jul; 19(4):317-326. PubMed ID: 34059188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis.
    Li X; Liu C; Mao Z; Xiao M; Wang L; Qi S; Zhou F
    Crit Care; 2020 Nov; 24(1):647. PubMed ID: 33198786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review and meta-analysis of the effect of ABO blood group on the risk of SARS-CoV-2 infection.
    Balaouras G; Eusebi P; Kostoulas P
    PLoS One; 2022; 17(7):e0271451. PubMed ID: 35901063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Storm of soluble immune checkpoints associated with disease severity of COVID-19.
    Kong Y; Wang Y; Wu X; Han J; Li G; Hua M; Han K; Zhang H; Li A; Zeng H
    Signal Transduct Target Ther; 2020 Sep; 5(1):192. PubMed ID: 32895366
    [No Abstract]   [Full Text] [Related]  

  • 39. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis.
    Kumar A; Arora A; Sharma P; Anikhindi SA; Bansal N; Singla V; Khare S; Srivastava A
    Diabetes Metab Syndr; 2020; 14(4):535-545. PubMed ID: 32408118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.